Simon Harnest

Simon Harnest currently serves as the Chief Financial Officer at Totus Medicines, a position held since January 2025. Prior to this, Simon was the Chief Investment Officer at Metagenomi from July 2021 to January 2025 and held multiple senior roles, including Chief Investment Officer and Senior Vice President of Corporate Strategy and Finance at Cellectis between March 2015 and June 2021. Simon's extensive experience in corporate strategy and finance includes roles as Vice President at Calyxt, The Trout Group, and Trout Capital LLC. Simon began their career as an Associate at Deutsche Bank in 2007. Academically, Simon holds a Master of Science in Public Health from The London School of Economics and Political Science and a Bachelor of Science in Economics from the University of Westminster, along with a concert diploma and diploma in Classical Flute from music schools in Paris.